undefined undefined
NaN.000
NaN.00%
Fortress Biotech press release (NASDAQ:FBIO): Q1 GAAP EPS of -$1.03 beats by $0.70. Revenue of $13M (+4.6% Y/Y) misses by $1.13M. Shares -0.29%. More on Fortress Biotech Journey Medical announces U.S....
05-16 04:54
Fortress Biotech (NASDAQ:FBIO) reported quarterly losses of $(0.53) per share which beat the analyst consensus estimate of $(1.97) by 73.1 percent. This is a 55.83 percent increase over losses of $(1.20) per share from
03-29 11:33
Mustang Bio (NASDAQ:MBIO) stock was up 9% in late morning trading Thursday after the company said it was planning to expand testing of its oncology drug candidate MB-106 into autoimmune diseases. The ...
03-28 23:09
Roth MKM analyst Jason Wittes reinstates Fortress Biotech (NASDAQ:FBIO) with a Buy and announces $10 price target.
03-15 20:52
Fortress Biotech, Inc. (NASDAQ:FBIO) shareholders are no doubt pleased to see t...
03-07 18:00
Ash Jayagopal, Ph.D., M.B.A. Appointed Chief Scientific and Development Officer Nirav Jhaveri, C.F.A, M.B.A. Appointed as Chief Financial OfficerFARMINGTON HILLS, Mich., Feb. 14, 2024 (GLOBE NEWSWIRE) -- Ocuphire
02-14 21:17
$1.5M Bet On This Healthcare Stock? Check Out These 4 Penny Stocks Insiders Are Aggressively Buying
01-10 21:09
To the annoyance of some shareholders, Fortress Biotech, Inc. (NASDAQ:FBIO) sha...
01-09 06:40
U.S. stocks traded lower toward the end of trading, with the Dow Jones index falling more than 50 points on Friday. The Dow traded down 0.17% to 37,644.68 while the NASDAQ fell 0.48% to 15,022.70. The S&P 500 also fell, dropping, 0.33% to 4,767.78.
2023-12-30 03:21
Cyprium received $4.5 million payment upon closing and remains eligible to rece...
2023-12-06 09:41